Weekly NIH Funding Announcements

Weekly NIH Funding Opportunities and Announcements

• Notice of Change to Funding Opportunity: Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed)

  October 5, 2022

• Notice of Training and REDCap Demonstration for the Implementation of NICHD's CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) Portal

  October 5, 2022

• Immunity in Older Adults (U01 Clinical Trial Not Allowed)

  October 4, 2022

• Notice of Correction to Application and Submission Information for RFA-NS-22-029 "Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)"

  October 4, 2022

• Notice of Change to Eligible Organizations in PAR-22-250 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)"

  October 4, 2022

• Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed)

  October 4, 2022

• Notice of Intent to Publish Funding Opportunity Announcements for Community Level Interventions to Prevent Firearm and Related Violence, Injury and Mortality

  October 3, 2022

• INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed)

  October 3, 2022

• Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project

  October 3, 2022

• Notice of Special Interest (NOSI): Targeting the Pathogen within the Arthropod Vector

  October 3, 2022

• Notice of Intent to Publish a Funding Opportunity Announcement for NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

  October 3, 2022

• Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33 Clinical Trial Not Allowed)

  October 3, 2022

• Genetic Tools for Understanding Rickettsial and Related Infections (R61/R33 Clinical Trial Not Allowed)

  October 3, 2022

• Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32)

  October 3, 2022

• NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)

  October 3, 2022

• NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)

  October 3, 2022

• Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)

  October 3, 2022

• Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)

  October 3, 2022

• BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)

  October 3, 2022

• BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (R01 Clinical Trial Not Allowed)

  October 3, 2022

• BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)

  October 3, 2022

• Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)

  October 3, 2022

• Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required)

  October 3, 2022

• Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

  October 3, 2022

• Notice of Special Interest (NOSI): Understanding Exposure and Health Effects of Micro and/or Nanoplastics

  October 3, 2022

• Reminder: NIH Natural Disaster Policy Hurricanes Fiona and Ian

  October 3, 2022

• Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required)

  October 3, 2022

• Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R01 Clinical Trial Not Allowed)

  October 3, 2022

• Biological Basis for how Environmental Exposures Impact Risk for Psychiatric Disorders (R21 Clinical Trial Not Allowed)

  October 3, 2022

• Notice to Extend PA-20-028, Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)

  October 3, 2022

• Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)

  October 3, 2022